Fund shareholders of Biogen Inc
ISIN US09062X1037 · United States · LEI W8J5WZB5IY3K0NDQT671
- Fund shareholders
- 822
- Of which ETFs
- 257 565 other funds
- Value held
- ≈ 15.1B $ 14.9B $ · 1.3B SEK · 50.6M €
- Share of capital
- 48.4 % of 147.8M shares on Jul 27, 2026
822 funds hold this company. This table lists the 818 that declare it in a regulatory filing. The other 4 publish their holdings in their own reports. The “Fund reports” tab lists them, with their weight.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| MERCH-FONTEMAR, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 1.8M € | 3.29 % | as of Dec 31, 2025 ↗ | ||
| MORINVEST, SICAV, S.A. BBVA ASSET MANAGEMENT, S.A., SGIIC | 946K € | 0.14 % | as of Dec 31, 2025 ↗ | ||
| FONDMAPFRE RENTA MIXTO, FI MAPFRE ASSET MANAGEMENT, SGIIC, S.A. | 625K € | 0.36 % | as of Dec 31, 2025 ↗ | ||
| BBVA USA DESARROLLO CUBIERTO, FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 558K € | 0.40 % | as of Dec 31, 2025 ↗ | ||
| BINDEX USA INDICE, FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 515K € | 0.04 % | as of Dec 31, 2025 ↗ | ||
| ING DIRECT FONDO NARANJA STANDARD & POOR´S 500, FI AMUNDI IBERIA, SGIIC, S.A. | 477.5K € | 0.05 % | as of Dec 31, 2025 ↗ | ||
| FONDMAPFRE ELECCION MODERADA, F.I. MAPFRE ASSET MANAGEMENT, SGIIC, S.A. | 453.5K € | 0.13 % | as of Dec 31, 2025 ↗ | ||
| FONDMAPFRE ELECCION PRUDENTE, F.I. MAPFRE ASSET MANAGEMENT, SGIIC, S.A. | 429.5K € | 0.14 % | as of Dec 31, 2025 ↗ | ||
| DUNAS SELECCIÓN USA ESG CUBIERTO FI DUNAS CAPITAL ASSET MANAGEMENT S.G.I.I.C., S.A. | 274.4K € | 0.08 % | as of Dec 31, 2025 ↗ | ||
| FONDMAPFRE ELECCIÓN DECIDIDA, F.I. MAPFRE ASSET MANAGEMENT, SGIIC, S.A. | 211.4K € | 0.21 % | as of Dec 31, 2025 ↗ | ||
| RENTA 4 UNIVERSAL, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 149.8K € | 1.95 % | as of Dec 31, 2025 ↗ | ||
| TOP CLASS HEALTHCARE, FI RENTA 4 GESTORA, S.G.I.I.C., S.A. | 149.8K € | 1.12 % | as of Dec 31, 2025 ↗ | ||
| SIGMA INVESTMENT HOUSE HEALTHCARE, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 137.7K € | 0.35 % | as of Dec 31, 2025 ↗ | ||
| COMPROMISO MEDIOLANUM, FI MEDIOLANUM GESTION, S.G.I.I.C., S.A. | 126.6K € | 0.31 % | as of Dec 31, 2025 ↗ | ||
| BBVA BOLSA INDICE USA (CUBIERTO), FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 110K € | 0.04 % | as of Dec 31, 2025 ↗ | ||
| ESPECTRUM I ESTRATEGIES INVESTMENT, S.A. SICAV GESALCALA, S.A., S.G.I.I.C. | 82.4K € | 1.90 % | as of Dec 31, 2025 ↗ | ||
| BINDEX USA SCREENED ÍNDICE (CUBIERTO), FI BBVA ASSET MANAGEMENT, S.A., SGIIC | 51K € | 0.06 % | as of Dec 31, 2025 ↗ | ||
| GESTION BOUTIQUE VIII, FI GESTION BOUTIQUE VIII / VETUSTA INVERSIÓN ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 21.4K € | 0.90 % | as of Dec 31, 2025 ↗ |
Funds that publish their own holdings
| Fund | Weight in fund | |
|---|---|---|
| Edmond de Rothschild Fund - Healthcare Edmond de Rothschild Asset Management (Luxembourg) | 2.94 % | as of Mar 31, 2026 ↗ |
| Pictet - Biotech Pictet Asset Management (Europe) S.A. | 2.71 % | as of Sep 30, 2025 ↗ |
| Amundi Dynamique Climat Amundi Asset Management | 0.03 % | as of Sep 30, 2025 ↗ |
| Pictet - USA Index Pictet Asset Management (Europe) S.A. | 0.03 % | as of Sep 30, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Invesco Biotechnology & Genome ETF Invesco Exchange-Traded Fund Trust | 4.79 % | as of Jul 31, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 4.18 % | as of Jul 31, 2026 ↗ |
| MERCH-UNIVERSAL, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 4.15 % | as of Dec 31, 2025 ↗ |
| First Trust Nasdaq Pharmaceuticals ETF First Trust Exchange-Traded Fund VI | 3.84 % | as of Jun 30, 2026 ↗ |
| VanEck Biotech ETF VanEck ETF Trust | 3.63 % | as of Jun 30, 2026 ↗ |
| iShares Health Innovation Active ETF BlackRock ETF Trust | 3.52 % | as of Jul 31, 2026 ↗ |
| MERCHFONDO, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 3.45 % | as of Dec 31, 2025 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 3.37 % | as of Jun 30, 2026 ↗ |
| MERCH-FONTEMAR, FI ANDBANK WEALTH MANAGEMENT, SGIIC, S.A.U. | 3.29 % | as of Dec 31, 2025 ↗ |
| Hennessy Sustainable ETF Hennessy Funds Trust | 3.11 % | as of Jul 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 757 | -9 | 70,785,787 | +5.5 % |
| 2026Q2 | 766 | +47 | 67,078,108 | +6.5 % |
| 2026Q1 | 719 | -1 | 62,971,523 | +5.5 % |
| 2025Q4 | 720 | +20 | 59,708,137 | -2.5 % |
| 2025Q3 | 700 | -22 | 61,228,423 | -2.0 % |
| 2025Q2 | 722 | +8 | 62,471,837 | -1.2 % |
| 2025Q1 | 714 | -49 | 63,217,302 | -2.5 % |
| 2024Q4 | 763 | -14 | 64,810,261 | -3.6 % |
| 2024Q3 | 777 | -4 | 67,231,656 | +1.9 % |
| 2024Q2 | 781 | -46 | 65,957,473 | +7.9 % |
| 2024Q1 | 827 | -55 | 61,122,879 | +2.1 % |
| 2023Q4 | 882 | 59,883,539 |
Institutional managers
987 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 15,974,601 | 2.9B $ | as of Mar 31, 2026 |
| PRIMECAP MANAGEMENT CO/CA/ | 14,757,607 | 2.7B $ | as of Mar 31, 2026 |
| FMR LLC | 12,807,541 | 2.3B $ | as of Mar 31, 2026 |
| STATE STREET CORP | 7,167,922 | 1.3B $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 4,342,602 | 793.4M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 2,961,641 | 543M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,170,940 | 398M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 2,016,009 | 378.1M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 1,923,557 | 346.2M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 1,745,255 | 320M $ | as of Mar 31, 2026 |
| Boston Partners | 1,700,078 | 311.7M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 1,446,579 | 265.2M $ | as of Mar 31, 2026 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1,377,568 | 252.5M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 1,349,832 | 247.5M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 1,160,989 | 212.8K $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 1,156,369 | 212M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1,149,394 | 210.7M $ | as of Mar 31, 2026 |
| VAN ECK ASSOCIATES CORP | 1,079,861 | 198K $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,079,119 | 197.9M $ | as of Mar 31, 2026 |
| DEUTSCHE BANK AG\ | 1,063,828 | 195M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,051,094 | 192.7M $ | as of Mar 31, 2026 |
| Pictet Asset Management Holding SA | 913,328 | 168.3M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 809,617 | 148.4M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 805,050 | 147.6M $ | as of Mar 31, 2026 |
| Amundi | 790,827 | 145M $ | as of Mar 31, 2026 |
Declared shareholders of Biogen Inc
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| FMR LLC and 1 other | 12.40 % | 18,294,524 | as of Jun 30, 2026 · SCHEDULE 13G |
Funds holding the debt of Biogen Inc
192 funds declare 394 bond lines of this company. The table shows the 25 largest holdings. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Fund shareholders of Biogen Inc". https://titelia.com/en/stocks/biogen-inc-US09062X1037